Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
X Chen, T Zhang, W Su, Z Dou, D Zhao, X Jin… - Cell Death & …, 2022 - nature.com
TP53, a crucial tumor suppressor gene, is the most commonly mutated gene in human
cancers. Aside from losing its tumor suppressor function, mutant p53 (mutp53) often …
cancers. Aside from losing its tumor suppressor function, mutant p53 (mutp53) often …
p53 isoforms and their implications in cancer
M Vieler, S Sanyal - Cancers, 2018 - mdpi.com
In this review we focus on the major isoforms of the tumor-suppressor protein p53,
dysfunction of which often leads to cancer. Mutations of the TP53 gene, particularly in the …
dysfunction of which often leads to cancer. Mutations of the TP53 gene, particularly in the …
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease
KM Farmer, G Ghag, N Puangmalai… - Acta neuropathologica …, 2020 - Springer
The transcription factor, p53, is critical for many important cellular functions involved in
genome integrity, including cell cycle control, DNA damage response, and apoptosis …
genome integrity, including cell cycle control, DNA damage response, and apoptosis …
p53 amyloid aggregation in cancer: function, mechanism, and therapy
J Li, M Guo, L Chen, Z Chen, Y Fu, Y Chen - Experimental Hematology & …, 2022 - Springer
Similar to neurodegenerative diseases, the concept that tumors are prion like diseases has
been proposed in recent years. p53, the most well-known tumor suppressor, has been …
been proposed in recent years. p53, the most well-known tumor suppressor, has been …
Aberrant phase separation and cancer
K Taniue, N Akimitsu - The FEBS journal, 2022 - Wiley Online Library
Eukaryotic cells are intracellularly divided into numerous compartments or organelles, which
coordinate specific molecules and biological reactions. Membrane‐bound organelles are …
coordinate specific molecules and biological reactions. Membrane‐bound organelles are …
Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands
EC Petronilho, MM Pedrote, MA Marques… - Chemical …, 2021 - pubs.rsc.org
Mutant p53 tends to form aggregates with amyloid properties, especially amyloid oligomers
inside the nucleus, which are believed to cause oncogenic gain-of-function (GoF). The …
inside the nucleus, which are believed to cause oncogenic gain-of-function (GoF). The …
Inhibition of p53 protein aggregation as a cancer treatment strategy
K Kwan, O Castro-Sandoval, C Gaiddon… - Current Opinion in …, 2023 - Elsevier
The p53 protein plays a critical role in the prevention of genome mutations in the body,
however, this protein is frequently mutated in cancer and almost all cancers exhibit …
however, this protein is frequently mutated in cancer and almost all cancers exhibit …
p53 amyloid formation leading to its loss of function: implications in cancer pathogenesis
The transcriptional regulator p53 has an essential role in tumor suppression. Almost 50% of
human cancers are associated with the loss of p53 functions, where p53 often accumulates …
human cancers are associated with the loss of p53 functions, where p53 often accumulates …
Targeting the prion-like aggregation of mutant p53 to combat cancer
Conspectus Prion-like behavior of several amyloidogenic proteins has been demonstrated
in recent years. Despite having functional roles in some cases, irregular aggregation can …
in recent years. Despite having functional roles in some cases, irregular aggregation can …
p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells
LP Rangel, GDS Ferretti, CL Costa… - Journal of Biological …, 2019 - ASBMB
p53 mutants can form amyloid-like structures that accumulate in cells. p53 reactivation with
induction of massive apoptosis-1 (PRIMA-1) and its primary active metabolite, 2-methylene …
induction of massive apoptosis-1 (PRIMA-1) and its primary active metabolite, 2-methylene …